DexCom, Inc. DXCM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.10B | 4.97B | 4.82B | 4.66B | 4.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.10B | 4.97B | 4.82B | 4.66B | 4.52B |
| Cost of Revenue | 1.87B | 1.86B | 1.85B | 1.86B | 1.85B |
| Gross Profit | 3.24B | 3.10B | 2.96B | 2.80B | 2.67B |
| SG&A Expenses | 1.41B | 1.36B | 1.33B | 1.29B | 1.30B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.88B | 3.83B | 3.78B | 3.75B | 3.74B |
| Operating Income | 1.22B | 1.14B | 1.03B | 911.80M | 777.70M |
| Income Before Tax | 1.26B | 1.28B | 1.20B | 1.09B | 959.00M |
| Income Tax Expenses | 271.40M | 280.30M | 273.20M | 252.10M | 238.30M |
| Earnings from Continuing Operations | 991.00 | 999.70 | 930.40 | 836.30 | 720.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 991.00M | 999.70M | 930.40M | 836.30M | 720.70M |
| EBIT | 1.22B | 1.14B | 1.03B | 911.80M | 777.70M |
| EBITDA | 1.50B | 1.40B | 1.29B | 1.16B | 1.02B |
| EPS Basic | 2.60 | 2.59 | 2.39 | 2.14 | 1.84 |
| Normalized Basic EPS | 2.08 | 1.95 | 1.80 | 1.62 | 1.41 |
| EPS Diluted | 2.55 | 2.53 | 2.34 | 2.09 | 1.80 |
| Normalized Diluted EPS | 2.03 | 1.90 | 1.75 | 1.56 | 1.35 |
| Average Basic Shares Outstanding | 1.53B | 1.55B | 1.56B | 1.56B | 1.56B |
| Average Diluted Shares Outstanding | 1.57B | 1.59B | 1.61B | 1.62B | 1.63B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |